BACKGROUND & AIMS:Large, population-based studies that have included the full spectrum of cirrhosis estimating survival, taking into account time-at-risk are lacking. We aimed to report 1- and 5-year average survival rates for people with cirrhosis to be used in a clinical and healthcare policy setting.METHODS:We used the Clinical Practice Research Datalink and linked English Hospital Episode Statistics to identify adult cases of cirrhosis from January 1998 to December 2009. We estimated 1- and 5-year survival according to whether time-at-risk was ambulatory or followed an emergency hospital admission related to liver disease, stratified by age, sex, and aetiology to be used in a clinical setting. We used a multivariate Cox-proportional haz...
Objective: Chronic liver disease continues to be a significant cause of morbidity and mortality yet ...
Objectives: The prevalence of liver cirrhosis is increasing, and many patients have acute conditio...
Objective Chronic liver disease continues to be a significant cause of morbidity and mortality yet r...
BACKGROUND & AIMS: Large, population-based studies that have included the full spectrum of cirrhosi...
Background: Mortality due to cirrhosis has tripled over the last 30 years in the UK. However, we lac...
OBJECTIVES: There is a need for unbiased estimates of cause-specific mortality by etiology in patien...
ObjectivesThere is a need for unbiased estimates of cause-specific mortality by etiology in patients...
Objectives: Mortality due to liver disease (of which cirrhosis is the end‐stage) is increasing more ...
Introduction Liver cirrhosis is increasing worldwide and associated with high mortality. Precise es...
OBJECTIVES:There is no routine registration of the occurrence of newly diagnosed cases of cirrhosis ...
ObjectivesMortality due to liver disease (of which cirrhosis is the end stage) is increasing more th...
The purpose of this study was to produce two statistical survival models in those with cirrhosis uti...
Objective: Chronic liver disease continues to be a significant cause of morbidity and mortality yet ...
Objectives: The prevalence of liver cirrhosis is increasing, and many patients have acute conditio...
Objective Chronic liver disease continues to be a significant cause of morbidity and mortality yet r...
BACKGROUND & AIMS: Large, population-based studies that have included the full spectrum of cirrhosi...
Background: Mortality due to cirrhosis has tripled over the last 30 years in the UK. However, we lac...
OBJECTIVES: There is a need for unbiased estimates of cause-specific mortality by etiology in patien...
ObjectivesThere is a need for unbiased estimates of cause-specific mortality by etiology in patients...
Objectives: Mortality due to liver disease (of which cirrhosis is the end‐stage) is increasing more ...
Introduction Liver cirrhosis is increasing worldwide and associated with high mortality. Precise es...
OBJECTIVES:There is no routine registration of the occurrence of newly diagnosed cases of cirrhosis ...
ObjectivesMortality due to liver disease (of which cirrhosis is the end stage) is increasing more th...
The purpose of this study was to produce two statistical survival models in those with cirrhosis uti...
Objective: Chronic liver disease continues to be a significant cause of morbidity and mortality yet ...
Objectives: The prevalence of liver cirrhosis is increasing, and many patients have acute conditio...
Objective Chronic liver disease continues to be a significant cause of morbidity and mortality yet r...